checkAd
    Startseite > Aktien > Sight Sciences > Nachrichten
    Sight Sciences Aktie
    5,5100
     
    USD
    -5,16 %
    -0,3000 USD
    Letzter Kurs 19:08:26 Nasdaq
    5,4700
     
    USD
    100 STK
    Geldkurs 19:08:58
    5,5100
     
    USD
    200 STK
    Briefkurs 19:08:58
    ISIN: US82657M1053 · WKN: A3CU4L · SYM: SGHT · USA

    Neueste Nachrichten

    Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
    07.05.24 · globenewswire · Sight Sciences
    Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
    02.05.24 · globenewswire · Sight Sciences
    Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
    29.04.24 · globenewswire · Sight Sciences
    Sight Sciences to Report First Quarter Financial Results on May 2, 2024
    18.04.24 · globenewswire · Sight Sciences
    Sight Sciences gibt die Veröffentlichung einer groß angelegten, praxisnahen MIGS-Studie als Nachweis für die Wirksamkeit des umfassenden Verfahrens zur Wiederherstellung des Kammerwasserabflusses mit der OMNI Surgical System-Technologie sowohl bei der Sen
    12.04.24 · globenewswire · Sight Sciences
    Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Y
    10.04.24 · globenewswire · Sight Sciences
    Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
    02.04.24 · globenewswire · Sight Sciences
    Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
    26.03.24 · globenewswire · Sight Sciences
    Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
    07.03.24 · globenewswire · Sight Sciences
    Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
    22.02.24 · globenewswire · Sight Sciences
    Sight Sciences Announces European Launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter Meeting
    14.02.24 · globenewswire · Sight Sciences
    Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital
    23.01.24 · globenewswire · Sight Sciences